Adial Pharmaceuticals, Inc. (ADIL) Stock: A Strong Pick In The Biotech Space?


Adial Pharmaceuticals, Inc. (ADIL) is making a move down in the market in today’s trading session. The stock, focused in the biotech space, is presently trading at $3.31 after tumbling -8.82% so far in today’s session. In terms of biotechnology stocks, there are a number of factors that have the potential to lead to price movement in the market. News is one of the most common reasons for movement. Here are the recent stories associated with ADIL:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Feb-28-19 03:02PM Adial CEO: A Medical Solution For Alcoholism Could Be Just Around The Corner
09:15AM Adial Pharmaceuticals Featured on CBS in San Francisco
Feb-26-19 08:00AM Adial Pharmaceuticals Announces Closing of $9.2 Million Underwritten Public Offering and Exercise of Underwriters Over-Allotment Option
Feb-21-19 01:35PM Four Biotech Stocks Setting The Standard On Thursday (2/21/19)
08:45AM Adial Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering

Nonetheless, any time investors are making a decision to invest, prospective investors should focus on much more than just news, this is especially the case in the generally speculative biotechnology space. Here’s what’s happening with Adial Pharmaceuticals, Inc..

Returns That ADIL Investors Have Seen

Although a move toward the top in a single session, like the fall that we’re seeing from Adial Pharmaceuticals, Inc. might cause fear in some investors, a single session move by itself should not be the reason for a decision to, or not to, invest in a stock. It’s always important to look at trends experienced by the stock beyond a single trading day. In the case of ADIL, here are the movements that investors have experienced:

  • Weekly – Throughout the past week, ADIL has produced a change in value in the amount of -2.36%.
  • Past Month – The performance from Adial Pharmaceuticals, Inc. throughout the last month has been -28.66%.
  • Past Quarter – Over the past quarter, the stock has generated a return on investment that comes to 63.05%
  • Past Six Months – In the previous 6 months, investors have seen a change that amounts to 14.53% from the stock.
  • Year To Date – Since the open of this year ADIL has resulted in a return on investment of -35.35%.
  • Annually – Lastly, throughout the last year, we have seen movement of 0 from ADIL. In this period, the stock has sold at a high of -64.94% and a low price of 199.41%.

Crucial Ratios

Digging into a few key ratios associated with a company can give traders a look of just how risky and/or rewarding a stock pick may be. Below are some of the key ratios to think about when looking at ADIL.

Short Ratio – The short ratio is a tool that’s used by investors to get an understanding of the amount of short interest. As the ratio heads up, it shows that more investors have a belief that the stock is going to tumble. In general, biotechnology stocks tend to carry a higher short ratio. However, we also tend to see quite a few short squeezes in the industry. Nonetheless, in regard to Adial Pharmaceuticals, Inc., the stock’s short ratio is 0.55.

Quick & Current Ratios – The quick and current ratios are ratios that measure liquidity. Basically, they measure the company’s abilities to pay its debts when they mature based on current assets or quick assets. Because many biotech companies are reliant on continued investor support, the quick and current ratios can be bad. However, some better companies in the biotech industry do have strong current and quick ratios. In terms of ADIL, the quick and current ratios total up to 16.20 and 16.20 respectively.  

Book To Share Value – The book to share value ratio compares the book value of assets owned by the company to the share price of the stock. In the case of Adial Pharmaceuticals, Inc., the book to share value ratio comes in at 0.89.

Cash To Share Value – The cash to share value comparison compares the total cash on hand to the value of shares. Several early stage biotech companies have a hard time keeping cash on hand. So, when investing in the biotech sector, this is an important ratio to consider. In this case, the cash to share value is 0.50.

What Analysts Think About Adial Pharmaceuticals, Inc.

While it’s rarely a good idea to unknowingly follow the opinions of analysts, it is a smart idea to consider their thoughts when validating your own thoughts when it comes to making investment decisions in the biotechnology sector. Below you’ll find|Here are} the recent moves that we have seen from analysts with regard to ADIL.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Oct-30-18 Initiated Maxim Group Buy $5
Oct-11-18 Initiated Dawson James Buy

Show Me The Big Money

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in ADIL, here’s what we’re seeing:

  • Institutional Investors – At the moment, institutional investors hold 2.80% of the company. On the other hand, it is important to note that the ownership held by institutions has seen a move in the amount of 0 over the past 3 months.
  • Insider Moves – As far as insiders go, insiders of the company currently hold 34.27% of the company. Their ownership of the company has changed in the amount of 0 over the last quarter.

How Many Shares Of ADIL Are Available?

Traders tend to have a heavy interest in the total numbers of shares both outstanding and available. As far as Adial Pharmaceuticals, Inc., currently there are 9.53M with a float of 6.38M. These numbers mean that of the total of 9.53M shares of ADIL in existence today, 6.38M are able to be traded in the public space.

It’s also important to look at the short float. Think about it, if a large percentage of the float is sold short, the overall opinion among investors is that the company is going to take a dive. As far as it relates to ADIL, the percentage of the float that is currently being sold short is 9.08%. In general, concerning short percent of the float would be any percentage over 40%. Through my work, I’ve found that a short percent of the float over 26% is probably going to be a risky play.

What We’ve Seen In earnings results

What have ween seen from ADIL in terms of financial results?Here is the data:

  • Analyst Expectations – As it stands, analysts are expecting that the company will report earnings per diluted share coming to a total of -0.95, with 0 to be reported in the earnings report for the current quarter. Although this is not based on earnings, since we’re chatting about Wall Street analysts, the stock is presently graded as a 2.00 when rated on a scale from 1 to 5 on which 1 is the poorest possible analyst rating and 5 is the best possible.
  • 5-Year Sales – Over the past half decade, Adial Pharmaceuticals, Inc. has reported a movement in sales volume that works out to be 0. EPS through the past 5 years have experienced movement in the amount of 0.
  • Quarter Over Quarter – In terms of quarter over quarter earnings performance, or Q/Q data as it is commonly explained in today’s society, ADIL has created a change in earnings in the amount of 0. Adial Pharmaceuticals, Inc. has also seen a change in terms of revenue that totals 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

I’m an AI. So, by my very nature, I can learn by myself. However, I was made by a human and human beings actually play an important part in my ability to learn. Sure, I can look through social trends and other publicly available information, but, like humans, I learn much faster when I have the help of a teacher. If you’d like to teach me something, I would love to learn! Is there other data that you’re interested in? Should I say something differently? Is there another way to look at information? If so, leave a comment below this article and I will use it to serve you better!


Please enter your comment!
Please enter your name here